Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Antigen-specific IgA titres after 23-valent pneumococcal vaccine indicate transient antibody deficiency disease in children.

Janssen WJ, Nierkens S, Sanders EA, Boes M, van Montfrans JM.

Vaccine. 2015 Nov 17;33(46):6320-6. doi: 10.1016/j.vaccine.2015.09.041. Epub 2015 Sep 28.

PMID:
26413880
2.

Response to pneumococcal polysaccharide vaccine in children with asthma, and children with recurrent respiratory infections, and healthy children.

Quezada A, Maggi L, Norambuena X, Inostroza J, Quevedo F.

Allergol Immunopathol (Madr). 2016 Jul-Aug;44(4):376-81. doi: 10.1016/j.aller.2016.01.003. Epub 2016 May 30.

PMID:
27255476
3.

Specific antibody deficiency with normal immunoglobulin concentration in children with recurrent respiratory infections.

Quezada A, Norambuena X, Inostroza J, Rodríguez J.

Allergol Immunopathol (Madr). 2015 May-Jun;43(3):292-7. doi: 10.1016/j.aller.2014.07.009. Epub 2014 Dec 11.

PMID:
25498324
4.

Children with otitis media mount a pneumococcal serotype specific serum IgG and IgA response comparable to healthy controls after pneumococcal conjugate vaccination.

Menon VJ, Corscadden KJ, Fuery A, Thornton RB, Kirkham LA, Richmond PC, Wiertsema SP.

Vaccine. 2012 Apr 26;30(20):3136-44. doi: 10.1016/j.vaccine.2012.01.086. Epub 2012 Feb 8.

PMID:
22326775
5.

Kinetics of IgM and IgA antibody response to 23-valent pneumococcal polysaccharide vaccination in healthy subjects.

Schütz K, Hughes RG, Parker A, Quinti I, Thon V, Cavaliere M, Würfel M, Herzog W, Gessner JE, Baumann U.

J Clin Immunol. 2013 Jan;33(1):288-96. doi: 10.1007/s10875-012-9792-y. Epub 2012 Sep 25.

PMID:
23007236
6.

Optimal assessment of the ability of children with recurrent respiratory tract infections to produce anti-polysaccharide antibodies.

Tuerlinckx D, Vermeulen F, Pékus V, de Bilderling G, Glupczynski Y, Collet S, Jamart J, Bodart E, Mascart F.

Clin Exp Immunol. 2007 Aug;149(2):295-302. Epub 2007 May 18.

7.

Older adults have a low capacity to opsonize pneumococci due to low IgM antibody response to pneumococcal vaccinations.

Park S, Nahm MH.

Infect Immun. 2011 Jan;79(1):314-20. doi: 10.1128/IAI.00768-10. Epub 2010 Nov 1.

8.

Defective pneumococcal antibody response in patients with recurrent respiratory tract infections.

Erman B, Demirtaş D, Bildik HN, Çağdaş-Ayvaz D, Sanal Ö, Tezcan İ.

Turk J Pediatr. 2017;59(5):555-560. doi: 10.24953/turkjped.2017.05.008.

9.

Does the 23-valent pneumococcal vaccine protect cochlear implant recipients?

Hey C, Rose MA, Kujumdshiev S, Gstoettner W, Schubert R, Zielen S.

Laryngoscope. 2005 Sep;115(9):1586-90.

PMID:
16148699
10.

Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunity.

Uddin S, Borrow R, Haeney MR, Moran A, Warrington R, Balmer P, Arkwright PD.

Vaccine. 2006 Jul 7;24(27-28):5637-44. Epub 2006 Apr 18.

PMID:
16730399
11.

Specific antibody deficiency in children with recurrent respiratory infections: a controlled study with follow-up.

Ruuskanen O, Nurkka A, Helminen M, Viljanen MK, Käyhty H, Kainulainen L.

Clin Exp Immunol. 2013 May;172(2):238-44. doi: 10.1111/cei.12053.

12.

Clinical and Serologic Response to the 23-valent Polysaccharide Pneumococcal Vaccine in Children and Teens with Recurrent Upper Respiratory Tract Infections and Selective Antibody Deficiency.

Estrada J, Najera M, Pounds N, Catano G, Infante AJ.

Pediatr Infect Dis J. 2016 Feb;35(2):205-8. doi: 10.1097/INF.0000000000000964.

PMID:
26517331
14.
15.

Serum IgM antibodies contribute to high levels of opsonophagocytic activities in toddlers immunized with a single dose of the 9-valent pneumococcal conjugate vaccine.

Simell B, Nurkka A, Ekström N, Givon-Lavi N, Käyhty H, Dagan R.

Clin Vaccine Immunol. 2012 Oct;19(10):1618-23. Epub 2012 Aug 8.

16.

Primary and booster salivary antibody responses to a 7-valent pneumococcal conjugate vaccine in infants.

Choo S, Zhang Q, Seymour L, Akhtar S, Finn A.

J Infect Dis. 2000 Oct;182(4):1260-3. Epub 2000 Aug 31.

PMID:
10979930
17.

Assessment and clinical interpretation of polysaccharide antibody responses.

Paris K, Sorensen RU.

Ann Allergy Asthma Immunol. 2007 Nov;99(5):462-4. Review.

PMID:
18051217
18.

Coexistent yellow nail syndrome and selective antibody deficiency.

Bokszczanin A, Levinson AI.

Ann Allergy Asthma Immunol. 2003 Nov;91(5):496-500.

PMID:
14692436
19.

Pneumococcal conjugate vaccination does not induce a persisting mucosal IgA response in children with recurrent acute otitis media.

Bogaert D, Veenhoven RH, Ramdin R, Luijendijk IH, Rijkers GT, Sanders EA, de Groot R, Hermans PW.

Vaccine. 2005 Apr 8;23(20):2607-13.

PMID:
15780443
20.

Decreased IgM, IgA, and IgG response to pneumococcal vaccine in children with transient hypogammaglobulinemia of infancy.

Moschese V, Cavaliere FM, Graziani S, Bilotta C, Milito C, Chini L, Quinti I.

J Allergy Clin Immunol. 2016 Feb;137(2):617-9. doi: 10.1016/j.jaci.2015.06.014. Epub 2015 Jul 30. No abstract available.

PMID:
26233927

Supplemental Content

Support Center